<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38353350</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Pediatric pulmonology</Title><ISOAbbreviation>Pediatr Pulmonol</ISOAbbreviation></Journal><ArticleTitle>Incidence and risk factors for long COVID in children with COVID-19 pneumonia.</ArticleTitle><Pagination><StartPage>1330</StartPage><EndPage>1338</EndPage><MedlinePgn>1330-1338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.26910</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">There are only a few reports of long COVID including pulmonary function in children after COVID-19 pneumonia. We determined the incidence of long COVID and abnormal pulmonary function in those children and identify risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This cohort study enrolled children admitted with COVID-19 pneumonia during 2021-2022. We gathered clinical characteristics during admission and at follow-up 3 months after.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We determined the incidence of long COVID at 39.7% (95% confidence interval [CI]: 30.7%-49.1%). All severe pneumonia cases consistently reported persistent symptoms. Exercise intolerance, cough, and fatigue were the three most common persistent symptoms in 26 (22.4%), 21 (18.1%), and 18 (15.5%) of the patients, respectively. At the follow-up, 21 cases (18.1%) demonstrated persistent abnormal chest radiographs. Three cases (6.9%) demonstrated restrictive ventilatory defects. Among those, one case (2.3%) demonstrated concomitant diffusion defect. Three cases (6.0%) demonstrated exercise-induced hypoxemia after the 6-minute walk test. Comparing spirometry variables between children with long COVID and without revealed significant difference of FEF25-75 (z score) between two groups. Age [adjusted OR (95% CI): 1.13 (1.05-1.22), p value 0.002], allergic diseases [adjusted OR (95% CI): 4.05 (1.36-12.06), p value 0.012], and living in polluted areas [adjusted OR (95% CI): 2.73 (1.18-6.33), p value 0.019] were significantly associated with long COVID.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A significant percentage of children developed long COVID after COVID-19 pneumonia. We should give additional attention to those who have exercise intolerance, chronic cough, or fatigue, especially older children, severe cases, children with allergic diseases, and those living in polluted areas.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wongwathanavikrom</LastName><ForeName>Na-Bhadhra</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pulmonology,&#xa0;Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tovichien</LastName><ForeName>Prakarn</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5000-9930</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pulmonology,&#xa0;Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udomittipong</LastName><ForeName>Kanokporn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4995-4537</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pulmonology,&#xa0;Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palamit</LastName><ForeName>Apinya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pulmonology,&#xa0;Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiamduangtawan</LastName><ForeName>Pinyapach</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pulmonology,&#xa0;Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahoran</LastName><ForeName>Khunphon</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pulmonology,&#xa0;Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charoensittisup</LastName><ForeName>Pawinee</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pulmonology,&#xa0;Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>None</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Pulmonol</MedlineTA><NlmUniqueID>8510590</NlmUniqueID><ISSNLinking>1099-0496</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>30</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>7</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38353350</ArticleId><ArticleId IdType="doi">10.1002/ppul.26910</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>National Institute for Health and Care Excellence: Clinical Guidelines. COVID&#x2010;19 Rapid Guideline: Managing the Long&#x2010;Term Effects of COVID&#x2010;19. National Institute for Health and Care Excellence (NICE) Copyright &#xa9; NICE; 2020.</Citation></Reference><Reference><Citation>Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181(12):3995&#x2010;4009.</Citation></Reference><Reference><Citation>Leftin Dobkin SC, Collaco JM, McGrath&#x2010;Morrow SA. Protracted respiratory findings in children post&#x2010;SARS&#x2010;CoV&#x2010;2 infection. Pediatr Pulmonol. 2021;56(12):3682&#x2010;3687.</Citation></Reference><Reference><Citation>Klanidhi KB, Chakrawarty A, Bhadouria SS, et al. Six&#x2010;minute walk test and its predictability in outcome of COVID&#x2010;19 patients. J Educ Health Promot. 2022;11:58.</Citation></Reference><Reference><Citation>Lewis KL, Helgeson SA, Tatari MM, Mallea JM, Baig HZ, Patel NM. COVID&#x2010;19 and the effects on pulmonary function following infection: a retrospective analysis. EClinicalMedicine. 2021;39:101079.</Citation></Reference><Reference><Citation>Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of post&#x2010;acute lung complications of COVID&#x2010;19. Radiology. 2021;301(2):E383&#x2010;E395.</Citation></Reference><Reference><Citation>Parisi GF, Indolfi C, Decimo F, Leonardi S, Miraglia Del Giudice M. COVID&#x2010;19 pneumonia in children: from etiology to management. Front Pediatr. 2020;8:616622.</Citation></Reference><Reference><Citation>Desoky SM, Andronikou S, Brody AS, Hirsch FW. Re: &#x201c;International Expert Consensus Statement on Chest Imaging in Pediatric COVID&#x2010;19 Patient Management: Imaging Findings, Imaging Study Reporting and Imaging Study Recommendations&#x201d;. Radiol Cardiothorac Imaging. 2020;2(3):e200305.</Citation></Reference><Reference><Citation>Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499.</Citation></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six&#x2010;minute walk test Am. J Respir Crit Care Med. 2002;166(1):111&#x2010;117.</Citation></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Ayuzo Del Valle NC, et al. Long&#x2010;COVID in children and adolescents: a systematic review and meta&#x2010;analyses. Sci Rep. 2022;12(1):9950.</Citation></Reference><Reference><Citation>Zheng YB, Zeng N, Yuan K, et al. Prevalence and risk factor for long COVID in children and adolescents: a meta&#x2010;analysis and systematic review. J Infect Public Health. 2023;16(5):660&#x2010;672.</Citation></Reference><Reference><Citation>Torres&#x2010;Castro R, Vasconcello&#x2010;Castillo L, Alsina&#x2010;Restoy X, et al. Respiratory function in patients post&#x2010;infection by COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Pulmonology. 2021;27(4):328&#x2010;337.</Citation></Reference><Reference><Citation>Iovine E, Di Mattia G, Nenna R, et al. Lung function after SARS&#x2010;CoV&#x2010;2 infection: a prospective cohort study in children. Pediatr Pulmonol. 2023;58(7):2009&#x2010;2016.</Citation></Reference><Reference><Citation>Blanco JR, Cobos&#x2010;Ceballos MJ, Navarro F, et al. Pulmonary long&#x2010;term consequences of COVID&#x2010;19 infections after hospital discharge. Clin Microbiol Infect. 2021;27(6):892&#x2010;896.</Citation></Reference><Reference><Citation>Knoke L, Schlegtendal A, Maier C, Eitner L, L&#xfc;cke T, Brinkmann F. Pulmonary function and long&#x2010;term respiratory symptoms in children and adolescents after COVID&#x2010;19. Front Pediatr. 2022;10:851008.</Citation></Reference><Reference><Citation>Bode SFN, Haendly M, Fabricius D, et al. Pulmonary function and persistent clinical symptoms in children and their parents 12 months after mild SARS&#x2010;CoV&#x2010;2 infection. Front Pediatr. 2022;10:894331.</Citation></Reference><Reference><Citation>Huang Y, Tan C, Wu J, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21(1):163.</Citation></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for post&#x2010;COVID&#x2010;19 condition in previously hospitalised children using the ISARIC Global follow&#x2010;up protocol: a prospective cohort study. Eur Respir J. 2022;59(2):2101341.</Citation></Reference><Reference><Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2010;754.</Citation></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Nemati H, Shahisavandi M, et al. Long COVID in children and adolescents. World J Pediatr. 2021;17(5):495&#x2010;499.</Citation></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid&#x2010;19 hyperinflammation and post&#x2010;Covid&#x2010;19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2010;332.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>